Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011946 · ClinicalTrials.gov registry record · NA
Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast Cancer
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01011946 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 36 participants.
The verdict
NCT01011946, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if PEM scan can improve axillary lymph node staging by assessing if they are involved by cancer. Your doctor may refer you for a PEM scan, PEM stands for positron emission mammography, a relatively new and advanced application of positron emission tomography or PET scanning. For decades, PET has helped doctors diagnose and treat disease.
Interventions
- DEVICE Positron Emission Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01011946
The ClinicalTrials.gov registry entry for NCT01011946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positron Emission Mammography is the first listed.
NCT01011946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01011946 about?
NCT01011946 is a clinical study titled "Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast Cancer". The purpose of this study is to determine if PEM scan can improve axillary lymph node staging by assessing if they are involved by cancer. Your doctor may refer you for a PEM scan, PEM stands for positron emission mammography, a relatively new and advanced application of positron emission tomography...
What is the current status of trial NCT01011946?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2009-11. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01011946?
The interventions under investigation include: Positron Emission Mammography (DEVICE).
Who is sponsoring clinical trial NCT01011946?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.